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Abstract
The oral microbiome, the complex ecosystem of microbes inhabiting the human mouth, harbors several thousands of
bacterial types. The proliferation of pathogenic bacteria within the mouth gives rise to periodontitis, an inflammatory
disease known to also constitute a risk factor for cardiovascular disease. While much is known about individual species
associated with pathogenesis, the system-level mechanisms underlying the transition from health to disease are still poorly
understood. Through the sequencing of the 16S rRNA gene and of whole community DNA we provide a glimpse at the
global genetic, metabolic, and ecological changes associated with periodontitis in 15 subgingival plaque samples, four from
each of two periodontitis patients, and the remaining samples from three healthy individuals. We also demonstrate the
power of whole-metagenome sequencing approaches in characterizing the genomes of key players in the oral microbiome,
including an unculturable TM7 organism. We reveal the disease microbiome to be enriched in virulence factors, and
adapted to a parasitic lifestyle that takes advantage of the disrupted host homeostasis. Furthermore, diseased samples
share a common structure that was not found in completely healthy samples, suggesting that the disease state may occupy
a narrow region within the space of possible configurations of the oral microbiome. Our pilot study demonstrates the
power of high-throughput sequencing as a tool for understanding the role of the oral microbiome in periodontal disease.
Despite a modest level of sequencing (,2 lanes Illumina 76 bp PE) and high human DNA contamination (up to ,90%) we
were able to partially reconstruct several oral microbes and to preliminarily characterize some systems-level differences
between the healthy and diseased oral microbiomes.
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Introduction
Understanding the role of microbial communities in human
health is emerging as one of the most important and fascinating
biomedical challenges of our times [1,2,3,4]. Our body harbors an
enormous amount of microbial cells, estimated to exceed the
number of human cells by an order of magnitude [5]. These
microbes are organized into complex communities specifically
adapted to inhabit different niches of the human body, such as the
skin, and the respiratory, gastrointestinal, and urogenital tracts.
Such ecosystems carry a broad range of functions indispensable for
the wellbeing of the host [6]. At the same time, the rise of
pathogens within such communities, causing infection and
inflammation, constitutes an ongoing challenge in biomedical
research. This is especially true in light of the slow rate at which
new antibiotics are discovered [7], and the increase in the number
of microbes that can resist treatment [8,9]. In contrast to the
traditional view of individual pathogens being responsible for
disease onset, recent microbial ecosystem diversity analyses seem
to point to a new perspective in which the transition from health to
disease is attributed to a shift in the global balance of the microbial
flora rather than to the specific appearance of individual
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the connection between disease or infection and the dynamics of
the host-associated ecosystems are still poorly understood.
In this work, we focus on the role of the oral microbial
ecosystem in periodontal disease. Periodontal disease is the most
common infectious disease affecting tooth-supporting structures.
Left untreated, periodontitis can lead to, or aggravate existing
systemic conditions such as cardiovascular disease, diabetes,
pulmonary diseases, and obesity [14,15,16]. In dentistry, under-
standing the changes in the oral microbiome that foretell the early
stages of periodontitis and dental caries, the most prevalent
chronic oral diseases, may allow the better diagnosis and treatment
before the appearance of the telltale clinical manifestations of these
diseases (such as tissue damage in periodontal pockets or dental
hard tissue loss). The emergence and evolution of antibiotic
resistance in periodontal pathogens has affected the therapeutic
success rates for this disease [17,18]. New approaches are urgently
needed to help regain control over periodontal disease, and
microbiome studies offer a promising new angle of attack.
Unraveling the complex interactions that define the oral micro-
biome is a fundamental, but complex component of this endeavor.
Recent developments in systems biology make it possible to
perform quantitative modeling of genome-scale metabolic net-
works for individual microbial species [19,20] and have been
recently extended to explore small microbial consortia [21,22],
possibly paving the way for future quantitative studies of the
microbiome. However, at the ecosystem level, current modeling
efforts and quantitative analyses are heavily limited by the
unavailability of relevant data. Towards this goal, increasingly
accessible metagenomic sequencing approaches hold the promise
to enable a global systemic view of the human oral microbiome
[1,4,23]. Recent advances in sequencing technology are enabling
scientists to generate billions of nucleotide bases at a fraction of the
cost per base of traditional methods [24]. This deep sequencing
has revealed an unexpectedly high diversity of the human oral
microbiome: dental plaque pooled from 98 healthy adults
comprised about 10,000 microbial phylotypes [25] - an order of
magnitude higher than the previously reported 700 oral microbial
phylotypes as identified by cultivation or traditional cloning and
sequencing [26,27]. The total diversity of the global oral
microbiome can be estimated to be around 25,000 phylotypes
[25]. To date, however, we do not know how many of these
microbes contribute to periodontal disease, what metabolic
functions are key players in the transition from health to disease,
or how common or exclusive are the oral microbiomes of
unrelated healthy individuals.
Here we combine the collection of whole-community sequenc-
ing data with a number of computational analyses to provide a
snapshot of the microbial component of periodontal disease at a
high resolution. Specifically, we collected subgingival plaque
samples from healthy and periodontally affected patients and
subjected them to 16S rDNA analysis and deep sequencing in
order to explore their microbiome. Our analyses reveal a number
of trends in genomic diversity and biological function enrichment
during disease that allow us to formulate a novel hypothesis on the
nature of periodontal disease. We also demonstrate the power of
high-throughput sequencing approaches by reconstructing an
unculturable member of the TM7 group, complementing an initial
analysis that relied on single cell genomic approaches. We also
characterize several regions of variation within one of the
dominant members of the oral cavity, Actinomyces naeslundii. This
paper describes a genomic and metabolic examination of the
differences between the healthy and diseased periodontal micro-
biome.
Results and Discussion
A Deep Look at the Oral Microbiome in Health and
Disease
Current knowledge of the composition and functional spectrum
of the human oral microbiome is limited by the difficulty to culture
the majority of microbes that populate the oral cavity. We used
deep sequencing technology to overcome this limitation, and
produce a substantial genomic data set for the human microbiome
under health and periodontal disease conditions. Specifically, we
generated 16S rDNA data from five subjects (3 periodontally
healthy [H] and 2 chronic periodontitis [P] patients, Table 1). In
addition, a total of 495,195 16S rDNA sequences were generated
with the 454 FLX sequencing technology, yielding an average of
,30,000 sequences per sample after removing low-quality
sequences (roughly 3-times more sequences per sample than
generated in a recent survey of oral microbes [28]). A total of
272,709,876 sequence reads were generated using the Illumina
GAII platform, 76 bp, paired-end run (mean library size 207 bp)
from the whole metagenome of four of the above-mentioned
subjects (H1, H2, P1, and P2; Table 1). The low quality
nucleotides were trimmed from all sequences and fragments
matching to the human genome reference (NCBI release
GRCh37.p1) were removed from further analysis. The level of
human DNA contamination varied between different samples
averaging ,87% of the sample, i.e. the oral microbiome
represents just one eighth of the entire dataset or a total of
33,681,771 (12.4%) sequences (Table 1). This level of contamina-
tion is consistent with that observed in other studies, such as the
Human Microbiome Project (manuscript in preparation). Despite
the moderate yield (in terms of fraction of microbial sequences in
the data-set) our results show that valuable biological insights can
be derived from the data, thus indicating that informative and
clinically relevant whole-metagenomic analyses of the oral
microbiota can be conducted in a cost-effective manner.
Beyond the Taxonomical View of Periodontitis
The standard view of periodontitis, largely based on traditional
microbiological approaches, associates the disease with the rise
and damaging action of a small set of well-characterized
pathogens. A first question we wanted to address using our data
is whether, and to what extent, this traditional view still holds from
the vantage point of metagenomic sequencing. Taxonomic
profiling of the samples, whether derived from targeted 16S
rRNA sequencing or from whole-metagenomic data (WGS)
(Methods and Figure 1) reveals a community dominated, on
average, by the bacterial phyla Firmicutes, Actinobacteria,
Bacteroidetes, Fusobacteria and Proteobacteria, consistent with
previous studies [28,29]. Together, these groups account for 80–
95% of the entire oral microbiome. At the genus level we identify a
total of 55 distinct genera in the 16S rDNA data and 58 distinct
genera in the WGS data that are present at an abundance of 0.1%
or higher (an additional 73 and 62 rare genera can be found in the
16S rDNA and WGS data, respectively). The most abundant
genera comprise previously characterized oral bacteria: Actinomyces,
Prevotella, Streptococcus, Fusobacterium, Leptotrichia, Corynebacterium,
Veillonella, Rothia, Capnocytophaga, Selenomonas, Treponema, and TM7
genera 1 and 5.
The TM7 division was prevalent in our samples (11 out of 15
samples contain this division at .2% abundance), averaging 5.7%
(standard deviation 7.2) of the entire population in the 16S rDNA
data (WGS-based estimates also range ,6%), and up to 26.8% in
sample P11. This division was statistically enriched in diseased
samples (p,=0.05, Metastats [30], Figure 1). TM7 is a novel
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previous studies have shown microbes from this division to be
commonly found in the human oral flora but at relatively low
abundance, generally around 1% of the population [31,32],
though abundances as high as 8% were previously reported [6].
The high abundance of TM7 microbes present in our samples,
and their correlation with periodontal disease, indicate that the
prevalence of this poorly studied bacterial division within the oral
cavity, and its role in disease, have yet to be fully appreciated.
When comparing healthy and diseased samples we observe a
shift in the composition of the oral microbiota (Figure 1 and Table
S1), supporting the well characterized transition (p value,10
215
using Fisher’s exact test) from a gram-positive dominated
community in the healthy samples, to a gram-negative dominated
community in periodontal disease [12]. On one hand, our findings
recapitulate prior results that indicate that the gram-negative
genera Selenomonas [33,34], Prevotella [35], Treponema [36], Tannerella
[36], Haemophilus [37] and Catonella [38] are significantly enriched
in periodontal disease. Further, we have found a set of gram-
positive genera that are significantly enriched in healthy samples:
Streptococcus, Actinomyces, and Granulicatella. Surprisingly, however,
neither Fusobacterium, nor Porphyromonas were found to be signifi-
cantly more abundant in the periodontal disease samples, despite
being previously implicated in this disease [12,39]. This is likely
due to the high variance in the abundance of these organisms
across our samples, as well as the small sample size which affects
our statistical power.
Clustering analysis (Figure 1) reveals sample H31 (a control) to
have a microbiota most similar to the diseased samples. This
observation prompted a careful analysis of the clinical data
collected during sampling. The data revealed some symptoms of
mild periodontal disease (such as bleeding at probing time, see
Materials and Methods for more details) that were not found in
any of the other healthy samples, indicating that the microbiota
may shift into a disease state before the full clinical symptoms of
the disease are apparent. Also note that the diseased samples
(including H31) cluster together tightly while the healthy samples
are more widely distributed. This phenomenon is discussed in
more detail below.
Taxonomic enrichment, however, cannot fully explain the
etiology of periodontal disease. All organisms that exhibit an
enrichment in either healthy or diseased samples are present in all
the samples, irrespective of disease status, i.e. the mere presence of
pathogens in the periodontal pocket is not sufficient to trigger
periodontitis. The disease might be correlated with the presence of
specific virulence factors within the genomes of particular
pathogens, or might be initiated once the abundance of one or
more pathogens crosses a specific threshold. The mechanisms that
keep pathogenic bacteria ‘in check’ during health but allow them
to bloom during disease are not yet understood. These observa-
tions support our suggestion that a full understanding of
periodontal disease requires whole-genome and whole-system
analyses.
Metabolism, Virulence Factors and Drug and Metal
Resistance as Disease Signatures
In addition to providing a taxonomic overview, our metage-
nomic sequencing data contain high-resolution functional infor-
mation. We annotated the function of genes identified in the
assembled whole-metagenome data according to the KEGG
Orthology, and used the resulting data to compare the functional
potential of the oral microbiome in health and disease. The
metabolic profiles of healthy and diseased samples differ in a
number of important ways (Figure 2). The diseased microbiome is
enriched in metabolic functions that are consistent with a parasitic
Table 1. Summary of sample information including high-quality read counts, taxonomic assignment of most abundant genus in
each sample, and level of human contamination.
Phenotype
Subject
(Tooth) Clinical 16S rDNA Dominant genus Shotgun
Human
DNA Dominant genus
# Reads Sample # Reads Sample
Periodontal
disease
1(14) advanced 51,056 P11 Prevotella 9.7M P1 68.86% Prevotella
1(19) moderate 20,149 P12 Fusobacterium
1(30) moderate 41,355 P13 Prevotella
2(30) moderate 46,444 P21 Prevotella 4.9M P2 81.98% Prevotella
Healthy 3(1) healthy 23,702 H11 Streptococcus 12.4M H1 60.61% Streptococcus
3(2) healthy 44,869 H12 Peptostreptococcus
3(3) healthy 32,405 H13 Streptococcus
3(4) healthy 56,116 H14 Leptotrichia
4(3) healthy 6,205 H21 Streptococcus 6.7M H2 89.78% Actinomyces
4(14) healthy 35,356 H22 Actinomyces
4(19) healthy 14,110 H23 Neisseria
4(30) healthy 25,662 H24 Actinomyces
5(3) early 12,295 H31 Fusobacterium NA NA NA NA
5(19) healthy 30,891 H32 Kingella
5(30) healthy 12,605 H33 Actinomyces
The clinical labels represent: ‘healthy’ – healthy periodontal pocket; ‘early’ – early periodontal disease (bleeding under probing but no attachment loss), ‘moderate’ –
moderate periodontal disease; ‘advanced’ – advanced periodontal disease. For a description of the clinical parameters used to make these determinations see Materials
and Methods. The absence of metagenomic data from subject 5 is indicated with ‘NA’ in the appropriate cells.
doi:10.1371/journal.pone.0037919.t001
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the degradation of host tissue and from bacterial cells destroyed by
the host immune response (Table S2 for the statistical significance
of enrichment of individual processes). Among these are functions
for fatty acid metabolism and acetyl-coenzyme A degradation,
aromatic amino acid degradation, ferrodoxin oxidation, and
energy-coupling factor (ECF) class transporters. The periodontal
pocket has been previously shown to be enriched for such nutrients
in patients with periodontitis [40]. Several of these metabolic
functions have also been associated with an intracellular lifestyle
Figure 1. Relative abundance of genera in the samples estimated from 16S rDNA sequencing. * - genus significantly enriched in
cases; ˆ - genus significantly enriched in controls (p,=0.05, Metastats [30]). Only genera with .1% abundance in at least one sample were
included. Colors reflect relative abundance from low (red) to high (white). Sample H31 (control) clusters together with the diseased samples,
consistent with clinical observations of early symptoms of periodontal disease.
doi:10.1371/journal.pone.0037919.g001
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(e.g. ferrodoxin oxidation, and acetyl-CoA degradation), high-
lighting the diversity of survival strategies employed by the
microbes inhabiting the periodontal pocket during disease. Also
enriched in disease are a number of virulence factors such as the
presence of conjugative transposons, type IV secretion systems,
and the biosynthesis of toxic factors (e.g. acetone, butanol, and
ethanol biosynthesis), as well as the Lipid-A of lipopolysaccharide
(LPS) biosynthesis. LPS is a group of molecules known to trigger
host immune response and inflammation and their enrichment in
disease provides a possible explanation for the systemic impact of
periodontitis on the human host.
Finally, the periodontal disease samples are enriched in a
number of functions related to drug and metal resistance (mercury,
cobalt-zinc-cadmium). Mercury resistance has been previously
characterized as a common feature of oral bacteria, even in the
absence of mercury-containing amalgam, and is frequently
associated with antibiotic resistance [42]. The role drug resistance
plays in disease is, however, unclear as antibiotic resistance factors
are present in both healthy and diseased samples.
Comparatively, only a few pathways are significantly enriched
in the healthy microbiome (or depleted in the diseased
microbiome), including pathways for fatty acid biosynthesis,
purine metabolism, and glycerol-3-phosphate metabolism. Cer-
tain fatty acids have been shown to have a protective role in
periodontal health [43,44,45] and it is possible that some of
these are synthesized by the healthy microbiota. However, most
of what is known about the role of fatty acids in periodontal
health is based on nutritional studies and the contribution of the
oral microbiota has yet to be characterized. Glycerol-3-
phosphate is a lipid metabolite that has been shown to occur
in higher concentration in periodontal disease samples [46].
Our study hints that a possible explanation for this observation
is a decrease in the ability of the disease microbiome to
metabolize this compound. Also enriched are genes related to
homoserine metabolism, possibly related to quorum sensing
functions within the healthy microbiome, as homoserine
lactones are frequently used as quorum sensing molecules in
oral bacteria [47]. The enrichment, within our healthy samples,
of the reactions downstream of homo-serine lactone pathway
may indicate a fully functioning quorum sensing system,
allowing for the communication between organisms that is the
hallmark of a healthy biofilm system. In poly-microbial biofilms
it has been shown that mutants lacking quorum-sensing
molecules, while able to construct biofilms, are unable to obtain
the correct structure and thickness [48,49]. The depletion of
pathways related to quorum sensing in our diseased samples
may indicate a possible cause of disease progression due to the
inability of the healthy microbiome to maintain a protective
biofilm.
A Systems Level Perspective on Oral Disease
The functional characterization reported above suggests that,
beyond the taxonomic details, one can identify ecosystem-level
signatures of periodontal disease consistent with its clinical
manifestations. However, from the above analysis, it is still not
clear whether these signatures reflect isolated instances of disease-
related molecular processes, or fit into a coherent picture of the
disease as a predictably different state of the whole oral microbial
flora. We addressed this question by performing additional
analyses at different levels of resolution, and found that a major
systemic change seems to be identifiable between the healthy and
diseased microbiomes. The diseased samples harbor a more
diverse microbial community (as measured by the Shannon
diversity index, Figure 3A), yet clustering analysis at the taxonomic
level (Figure 1, Figure 3B) and in terms of enzyme content
(Figure 3C), as well as pairwise comparisons of individual healthy
and diseased samples based on tetramer (subsequences of length 4)
frequencies (Figure 3D), all indicate that disease samples are more
similar to each other than the healthy samples. In other words, the
diseased state appears to be associated with a constrained and
predictable region in the space of all possible states a microbiome
can take. Thus, although the periodontal disease microbiomes are
more diverse in terms of community structure, that structure is
quite similar across different patients. In contrast, the healthy
microbiome in any individual patient has relatively lower
taxonomic diversity, but its exact composition differs significantly
across patients.
Combined with the metabolic analyses described above, these
results suggest that some systems-level changes may be
associated with periodontal disease and the transition between
health and disease. Microbial consortia in healthy individuals
(Figure 4A) may rely on a highly diverse and rapidly changing
supply of nutrients, as well as on good availability of oxygen for
respiration. The relative paucity of enriched pathways in our
healthy case analysis may reflect the diversity of metabolic
pathways represented in the community. This is also supported
by the clustering analysis of 16S rDNA data (Figure 3B) and of
enzyme frequency data (Figure 3C), which show that the
healthy data points do not tend to cluster together (Figure 4A,
bottom left inset), and is consistent with a community with a
lower taxonomic diversity (Figure 3A). On the contrary, the
metabolic functions present in the microbial flora associated
with periodontal disease (Figure 4B) seem to display a significant
enrichment in specific metabolic pathways, compatible with an
oxygen poor environment [50], and the availability of amino
acids and lipids as major carbon sources. This may reflect the
invasion of microbial pathogens (e.g. Prevotella intermedia which is
enriched in the diseased samples) into human cells (both
epithelial cells and macrophages). The disease flora is rich in
lipid degradation pathways, as well as other known virulence-
related activities, such as LPS biosynthesis. In turn, the
consistency of the intracellular environment across different
patients may explain why the disease points tend to cluster
together in the Principal Component Analysis (PCA) plots. The
ensuing picture is that the disease state is an attractor in the
space of metabolic functions, with enrichment in cytotoxic and
parasitic functions.
De Novo Assembly of Oral Microbes
The analyses we presented above have focused either exclu-
sively on organisms (16S rDNA diversity) or biological function
(metabolic analysis), thus ignoring the important link between
organisms and the functions they perform. This connection can
only be made by reconstructing partial or entire organisms from
the community through metagenomic assembly. Currently, no
practical genome assemblers exist that are specifically designed for
large-scale metagenomic assembly, thus we relied on a hybrid
assembly approach that combined de novo assembly using
SOAPdenovo [51] (assembler used in a recent metagenomic
analysis of gut microbes [52]), and alignments against a collection
of oral microbes (Methods). The results shown in Table 2
demonstrate the power of this hybrid approach, which leads to
an average of 4.4 and 2.1 times larger (in terms of N50 contig size)
assemblies than de novo assembly and comparative assembly,
respectively. Despite the relatively low level of coverage in our
data, we obtain fairly contiguous assemblies (average N50 contig
size of 3.5 Kbp), and are able to assemble up to about 50% of the
Microbiome Deep Sequencing & Periodontal Disease
PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e37919Figure 2. Metabolic pathways present in our samples. Dark blue – significantly enriched in healthy samples (p,0.05, MetaPath [84]); Dark red–
significantly enriched in diseased samples (p,0.05, MetaPath). (Figure constructed with iPath [85]).
doi:10.1371/journal.pone.0037919.g002
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our previous observation that the periodontal disease samples are
more diverse, the corresponding assemblies are also more
fragmented (average N50 contig size is 1.2 Kbp in diseased
samples versus 5.8 Kbp in healthy samples). In addition, a pooled
assembly of all four samples results in dramatically increased
contig sizes (max contig size is 16.9 Kbp in pooled assembly versus
7.6 Kbp in individual assemblies), indicating these samples contain
closely related organisms.
Assembly of a TM7 Genome
As described above, we detected a higher presence of TM7
organisms in our samples than previously reported in literature.
TM7 is a novel candidate bacterial phylum without cultivated
Figure 3. Systems-level analysis reveals the disease state to occupy a narrow region within the space of possible states for the
microbiome. A – Shannon diversity calculated from 16S rDNA data is significantly higher in diseased samples (community is more diverse). B –
Principal Component Analysis of the taxonomic compositions from 16S rDNA (empty symbols) and pooled WGS data (filled symbols). Disease
samples cluster together in the bottom left corner. Sample H31 (tooth with incipient periodontal disease from an otherwise healthy patient) clusters
together with the disease samples. C – Principal component analysis of the enzyme content of samples based on metagenomic sequencing. The PCA
graph shows a tighter clustering of disease samples (red) relative to the healthy ones (blue). This suggests that the disease state may be linked to a
specific metabolic configuration, and that the space of disease configurations is more constrained than the healthy one. Replicates (forward/reverse
reads from one or two instrument lanes) are shown separately as identical symbols, and exhibit minimal metabolic variation within each sample. D –
Comparison of relative frequencies of tetramers (4 bp motifs) in metagenomic reads across disease cases (in red, P1 vs. P2) and across control cases
(in blue, H1 vs. H2). Based on the relative frequencies of tetramers, disease samples are more similar to each other (points lie along the diagonal) than
controls are to each other.
doi:10.1371/journal.pone.0037919.g003
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e37919Figure 4. Schematic representation of the putative metabolic lifestyle shifts associated with the change in microbial flora around
the tooth and gum tissue upon the transition from a healthy (A) to an advanced periodontal disease (B) state. The healthy state is
dominated by the bacterial genera Streptococcus, Fusobacterium, Actinomyces, and Corynebacterium, whereas the disease state is primarily dominated
by pathogenic genera such as Prevotella, Leptotrichia, Treponema, and Fusobacterium.
doi:10.1371/journal.pone.0037919.g004
Table 2. Assembly statistics of metagenomic shotgun reads for contigs that are .=300 bp using (1) SOAPdenovo, (2)
comparative assembly and (3) a hybrid approach that uses MINIMUS to combine the contigs from the previous two methods.
Sample Assembly approach # Contigs Length (Mbp) Max (Kbp) N50 (bp) N90 (bp) Reads assembled
# (M) %
P1 SOAPdenovo 22,226 11.8 12.0 583 368 1.2 12.45
Comparative 26,464 16.7 16.0 1113 598 1.3 13.21
Hybrid 37,213 24.6 16.0 1829 1025 2.3 23.42
P2 SOAPdenovo 12,966 6.3 3.3 352 0 6.7 14.23
Comparative 13,841 8.5 35.2 490 0 5.7 11.69
Hybrid 21,835 12.5 37.6 647 396 10.5 21.39
H1 SOAPdenovo 45,658 3.1 22.6 3042 1648 5.0 40.20
Comparative 46,036 3.3 18.6 2437 1559 3.5 28.21
Hybrid 63,688 5.1 19.0 7567 3953 6.7 53.18
H2 SOAPdenovo 18,048 10.6 12.7 616 352 1.7 25.51
Comparative 16,107 13.6 26.8 1543 689 2.2 32.33
Hybrid 20,339 17.6 110.0 3934 1099 3.1 45.88
Pool SOAPdenovo 98,051 54.9 15.7 2035 1342 8.1 24.12
Comparative 63,506 60.1 44.6 8415 5474 8.4 24.89
Hybrid 115,718 93.4 229.8 16896 9245 13.4 39.87
‘Pool’ represents the assembly of all four samples together. N50 or N90 is defined as the contig length such that equal or longer contigs produce 50% or 90% of
10 Mbp.
doi:10.1371/journal.pone.0037919.t002
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human oral flora but with very low abundances [31,32]. The first
sequence of a TM7 organism (TM7a) was generated through
single-cell isolation in a microfluidic device, followed by whole
genome amplification [53]. Due to the artifacts of the whole
genome amplification approach, the resulting assembly is fairly
fragmented (row 1 in Table 3). Here we relied on a hybrid
assembly approach to reconstruct a more complete version of this
genome, using the corresponding shotgun sequences generated in
our project. Briefly, we started with the pooled assembly of all our
samples and extracted all contigs that are mapped to the
previously sequenced TM7a genome, and scaffolded these contigs
using Bambus 2 [54]. Finally, we merged our TM7 assembly with
the previously published assembly, derived from single-cell
sequencing, in order to construct the most complete (to date)
assembly of an organism from the TM7 group. The final assembly
is still highly fragmented, comprising over 1,500 contigs (Table 3),
however it contains almost 50% more sequence than the single-cell
derived assembly (2.3 Mbp versus 1.7 Mbp), and the N50 contig
size is two times larger (790 bp versus 389 bp). These results
highlight the power of combining single-cell and metagenomic
approaches when reconstructing the genomes of unculturable
organisms from metagenomic samples (Figure S1 for the
distribution of contig sizes).
In addition, this improved TM7 genome assembly allows us to
identify 703 genes that were not present in the original assembly
(Methods for details). In order to evaluate the additional
information contained in these genes, we annotated them using
the COMBREX [55] system (Table S4). The analysis revealed
several potential virulence genes including an EmrB/QacA family
drug resistance transporter gene (Gene ID: 681_1) and two phage
proteins (Gene IDs: 386_2 and 1828_4). These genes are not
necessarily omissions from the original assembly, rather they could
represent de novo insertions into the TM7 genome present in our
sample. The set of ‘novel’ TM7 genes does, however, included
several housekeeping genes (e.g., 10 ribosomal protein genes not
present in the original assembly) which should be conserved across
TM7 genomes, thereby indicating that our assembly improves
upon our current understanding of the structure of the TM7
genome in addition to revealing strain-specific genomic variants.
Genomic Variation in Actinomyces Naeslundii
Close analysis of one of the most abundant organisms in our
samples (present at 24- and 6-fold coverage in samples H2 and H1,
respectively, Table 4), a relative of Actinomyces naeslundii MG1
(sequence ID SEQF1063 in the Human Oral Microbiome
Database (HOMD) database), provides evidence for structural
variations distinguishing this strain from the reference strain
originally isolated from a patient with mild gingivitis [56]. The
average similarity between the assembled metagenomic contigs
from our project and the reference sequence is 96.2% and 95.2%
for samples H1 and H2, respectively (second and sixth ring in
Figure 5). A number of genomic deletions with respect to the
reference strain are apparent in our samples, several of which
contain potential virulence factors. These differences could be
explained by the fact that the reference genome was isolated from
a patient with gingivitis, while in our samples the Actinomyces strains
are predominantly associated with healthy samples. Most striking
is a deletion at 2120 kbp containing a putative mobile element
encoding a mercury resistance locus (including a mercury
resistance gene, a site-specific recombinase, and an integrase).
Mercury resistance is commonly found in oral bacteria, frequently
associated with antibiotic resistance [42]. Interestingly, gene set
enrichment analysis of the entire metagenomic data-set reveals an
enrichment of mercury resistance genes in the diseased samples
(Table S2), possibly due to the association of these genes with
virulence loci. Several other deletions also appear to encode
virulence factors - a drug transporter (at position 580 kbp in the
reference strain) and an alcohol dehydrogenase gene (at position
165 kbp) – further underscoring the difference between the
pathogenic reference strain and the presumably commensal
Actinomyces strains found in our samples. Another two deletions
(at positions 20 kbp, and 1010 kbp) contain genes predicted to
encode proteins involved in secretion and response regulation.
These deletions occur at slightly different locations in the two
samples we analyzed, suggesting they may be subject to rapid
evolution.
Further evidence of the adaptation of Actinomyces to the oral
environment is revealed by the analysis of single nucleotide
polymorphism (SNP) densities. In Figure 5 (rings 6 and 8) we
highlight the regions of the genome that have higher than
expected SNP densities (.2 standard deviations from the mean).
The most polymorphic regions (Table S3) correspond to genes
predicted to be involved in the adaptation of an organism to its
environment: transcriptional regulators, known to evolve rapidly
in bacteria [57,58], and ABC transporters [59]. Another highly
polymorphic region occurs within the glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) gene, a virulence-associated
protein originally identified in Streptococci, which plays an
important role in the colonization of periodontal pockets by
interacting with plaque-forming bacteria [60]. GAPDH was also
shown to mediate the interactions between Streptococci and
Table 3. Assembly statistics (calculated on contigs .=300 bp) for HOMD TM7a reference sequences (row 1), hybrid assembly
from metagenomic shotgun reads (row 2), Bambus scaffolding of hybrid assembly (row 3), assembly from combining hybrid
assembly and the HOMD reference sequences (row 4), and Bambus scaffolding of ‘combined reference’ (row 5).
Assembly # Contigs Total Length Max Contig 3Mbp
N25 N50
HOMD TM7a reference genome 1,780 1.7Mbp 17.5 Kbp 1.9 Kbp 0.4 Kbp
Hybrid assembly 1,340 1.5Mbp 13.9 Kbp 1.8 Kbp NA
Scaffolds 874 1.6Mbp 20.9 Kbp 5.1K bp 0.5 Kbp
Combine reference 2,222 2.2Mbp 17.5 Kbp 2.9 Kbp 0.8 Kbp
Scaffolds 1,593 2.3Mbp 33.7 Kbp 7.2 Kbp 1.8 Kbp
The N25 and N50 are calculated assuming a 3 Mbp genome size.
doi:10.1371/journal.pone.0037919.t003
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Reference genome Length Sample # Contigs Total length
Depth of
coverage Max Contig N50 N90
Actinomyces naeslundii
MG1
,3Mbp H1 2850 ,2.8Mbp 6.2 14.5 Kbp 1.7 Kbp 0.1 Kbp
H2 1168 ,2.9Mbp 24.3 28.6 Kbp 5.5 Kbp 0.9 Kbp
The N50 and N95 are calculated based on the MG1 genome size.
doi:10.1371/journal.pone.0037919.t004
Figure 5. Comparative analysis of the Actinomyces naeslundii MG1 reference genome (HOMD SeqID SEQF1063), and assemblies from
samples H1 and H2. Counting from outside, the first ring is the reference genome with genes annotated by colored bands: orange bands are
conserved genes; green bands are genes involved in horizontal gene transfer; yellow bands are genes with known functions; black bands are genes
with unknown functions. Only regions that are associated with genomic variations are colored and annotated. The second and sixth rings are the
assembled contigs from sample H2 and H1. The heatmaps in the third and seventh rings represent the depth of coverage of the contigs with 5K bp
window and 100 bp step for sample H2 and H1. The histograms in the fourth and eighth rings represent the scaled SNP rate with 5 Kbp window and
100 bp step for sample H2 (max=0.08) and H1 (max=0.03). The purple bands in the fifth ring represent regions with significantly higher theta values
than average (p,=0.05). Image generated with Circos [86].
doi:10.1371/journal.pone.0037919.g005
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the colonization of the subgingival pocket by P. gingivalis. These
observations are consistent with previous findings of high-SNP
densities within genomic regions surrounding recombination
events [63].
Conclusions
Our study represents a novel step towards characterizing the
genomic composition of the microbial communities associated
with periodontal disease. We have demonstrated that the
subgingival microbiome can be effectively interrogated through
high-throughput sequencing, and that the resulting data provide
valuable insights into the molecular underpinnings of periodontal
disease.
Despite a relatively small amount of bacterial sequence data
recovered from our samples (primarily due to the high level of
human DNA contamination), a combination of comparative and
de novo assembly approaches was able to reconstruct large genomic
segments from several dominant organisms in our samples,
thereby allowing a better reconstruction of an unculturable TM7
organism (in conjunction with data generated through single cell
genomic approaches), and providing a glimpse at the genomic
variation (and possible association with virulence) within Actinomy-
ces genomes. Better assemblies were possible in samples that were
sequenced more deeply (e.g., sample H1), indicating the need to
sequence the oral environment more deeply than has been done in
this study. Furthermore, assembly quality roughly correlated with
disease status, partly confirming our observation (based on 16S
rDNA data) that diseased samples had a higher microbial
diversity. This observation also highlights a limitation of existing
assembly tools in dealing with genomic diversity, further under-
scoring the need for the development of metagenomic-specific
genome assemblers.
The analysis of the TM7 and Actinomyces genomes revealed
signatures consistent with recombination events possibly associated
with virulence factors. Lateral transfer of virulence determinants
through phages and recombination is well documented in the
bacterial world, leading to a partial separation between function
and phylogeny, thus, suggesting the need for metagenomic and
functional analyses as a complement to taxonomic surveys of host-
associated microbiota.
Taxonomic analyses of the data we generated are consistent
with a well-established community shift from a gram-positive
dominated healthy microbiome to a gram-negative dominated
diseased microbiome, which is also enriched in a number of oral
pathogens. The molecular mechanisms that underlie and cause
this transition are, however, unknown. Here we have shown that
functional information derived from whole-metagenomic data
provides a valuable complement to the taxonomic data and allows
us to develop a novel theory of periodontal disease. The healthy
state is highly regulated by the host immune system and
interactions between community members to maintain a commu-
nity dominated by few ‘‘good’’ microbes, usually gram-positive
Actinobacteria or Streptococci. The transition to periodontal
disease involves a disruption of the host-microbiome interactions
that results in a more even community structure composed by a
broad range of organisms that can thrive in the oral environment.
The presence of pathogens within this community can lead to the
clinical manifestations of periodontal disease, which in turn can
lead to additional changes in the community due to the increased
availability of nutrients released by the damaged tissue. As a result,
the periodontal disease microbiome eventually settles into a state
characterized by a diverse population of microbes adapted to a
parasitic lifestyle made possible by the disrupted host homeostasis.
One of the samples from our study was characterized by a
microbiota typical of a diseased state, yet the corresponding tooth
was just starting to show some of the clinical symptoms of disease.
This observation implies that dysbiosis precedes the clinical
manifestation of disease, and that the oral microbiota could be a
potential tool for the early diagnosis of periodontitis.
The large variability we observe between healthy samples, and
even between different teeth of a same person, highlights the
limitation of using data derived from cross-sectional studies to
define what the core ‘‘normal microbiome’’ means. Furthermore,
case-control studies are likely insufficient to determine the causal
agents of periodontal disease – the organisms found to dominate
the diseased microbiome (the ‘‘usual suspects’’ commonly
described in the literature) may simply be a symptom of the
disrupted subgingival environment rather than the primary cause
of disease. The ‘‘usual suspects’’ approach considers presence and
absence of specific bacteria to be the critical precondition for
disease, however, our data support a more nuanced approach that
considers quantitative and genomic differences as the critical
factors when moving from health to a diseased state. Longitudinal
studies are necessary to characterize the dynamic changes that
occur in the oral microbiome in response to environmental
changes (food intake, changes in the host, etc.) and to track the
transition between the healthy and diseased states, and the return
to health after treatment.
It is important to note that the analyses described above are a
preliminary pilot project with limited sample size, and our
observations must be confirmed in more extensive studies.
Furthermore, we focus on whether the microbiome has the
potential to perform certain biological functions, and on deter-
mining the relative fraction of the microbial population that can
perform a particular function. These results (as well as those of
similar metagenomic projects) must be complemented by exper-
imental studies aimed at determining whether the biological
processes statistically enriched in disease are actually active in the
subgingival pocket.
As others have previously reported, and as observed in the data
we have shown here, periodontal disease is the result of a
disruption of the complex interactions occurring within the
subgingival microbiome and between the microbiome and the
host. A full understanding of the etiology of periodontal disease
will only be possible through further in-depth systems-level
analyses of the host-microbiome interaction.
Materials and Methods
Subject Population
The subject population consisted of 5 patients who were in
good general health and were recruited between August and
November 2009 at the Clinical Research Center, Boston
University Goldman School of Dental Medicine. Written
informed consent was obtained from all enrolled individuals.
The study protocol was reviewed and approved by the
Institutional Review Board at the Boston University Medical
Center. All subjects had at least 12 natural teeth with .20 years
of age (age range, 28–45 years). Subjects diagnosed with chronic
periodontitis (n=2) were selected among those who had at least
six sites with probing depth $6 mm and attachment loss
$5 mm. Subjects in the control (periodontally healthy) group
had no pockets .3 mm and no attachment loss .2m ma ta n y
site with no signs of periodontal inflammation characterized by
bleeding on probing, redness, edema, and attachment loss, with
the exception of subject 5 where one of the teeth (# 3, sample
H31) exhibited mild bleeding at probing time consistent with
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by bleeding on probing, redness, edema, but no attachment loss
(pocket depth #4 mm). Sites from chronic periodontitis subjects
further characterized as mild, moderate or advanced periodontitis
sites based on the pocket depth. Mild periodontitis was
characterized with pockets .4 mm but not more than 5 mm;
moderate periodontitis was characterized with pockets .5b u t
,7 mm while advanced periodontitis was characterized with
pockets .7 mm. Healthy group consisted of subjects of Asian,
Caucasian and African American origin, while periodontitis
subjects were of Caucasian and African-American origin.
Exclusion criteria included pregnancy, lactation, systemic condi-
tions that could affect the progression or treatment of periodontal
diseases. In addition, none of the subjects had received systemic
antibiotics or periodontal therapy in the previous 6 months.
Subgingival Plaque Sampling and Isolation of Bacterial
DNA
After the removal of supragingival plaque with sterile gauze,
individual subgingival plaque samples were taken from the mesio-
buccal aspect of four molar teeth in four quadrants (upper right,
upper left, lower right and lower left) per subject using sterile
periodontal curettes (Hu-Friedy, Chicago, IL). Each sample was
placed in a separate sterile 1.5-ml tube containing 200 mlT E
buffer (50 mM Tris-HCl, 1 mM EDTA; pH 7.6). Bacterial DNA
extraction was performed using commercially available DNA
purification kit (Epicentre MasterPure
TM, Madison, WI) according
to manufacturer’s guidelines. First, the debris was separated by
centrifugation at 4uC and supernatant was transferred to another
microcentrifuge tube and pellet was discarded. The collected
supernatant was mixed with 500 ml of isopropanol and centrifuged
at 4uC for DNA isolation. Isopropanol solution was carefully
removed without dislodging the DNA pellet. The DNA pellet was
rinsed with 75% ethanol and residual ethanol was removed. The
sample was resuspended in 25 ml of TE buffer and stored at
280uC until analysis.
16S rDNA Sequencing Protocol
DNA samples were amplified using the primers: 59-
GCCTCCCTCGCGCCATCAGacacactgCATGCTGCCTCC-
CGTAGGAGT and 59-CCTATCCCCTGTGTGCCTTGG-
CAGTCTCAGAGAGTTTGATCCTGGCTCAG to initiate
the reaction. The underlined portions of the primers corre-
sponded to ‘universal’ bacterial primers 338R and 27F primer,
the small letters contained a barcode specific to each well and
the 59 end of the primer was specific to the 454 specific
protocols. Each reaction had 5 units of Choice DNA Taq
polymerase (Denville Scientific), 100 uM of dNTPs, 16reaction
buffer and 2 mM MgCl2 and occurred for 30 cycles of 94uCf o r
30 sec, 50uCf o r3 0s e c ,a n d7 2 uC for 30 sec. The presence of
amplified products was confirmed by gel electrophoresis.
Approximately equimolar amounts of product were pooled
and gel purified. Sequencing was performed using the Lib-L kit
following instructions from the manufacturer (Roche).
Data Collection, Sequencing and Preprocessing
16S rDNA sequences were processed and filtered based on
quality with an in-house pipeline as follows. First, sequences
containing at least one unrecognizable base-pair (‘N’), and that
were too short (,75 cycles of the 454 instrument) were excluded
from further analysis. Then, barcode sequences were deconvoluted
and removed.
Metagenomic sequencing was performed on pooled DNA from
multiple teeth in order to obtain sufficient DNA concentrations for
library construction. Metagenomic shotgun sequences were
obtained from the Illumina instruments in fastq format and were
trimmed for quality using the FastX Toolkit (Hannon Lab, CSHL)
with the following parameters: (1) minimum length 25, and (2) q-
value cutoff 20. Sequences containing at least one ambiguity
character (‘N’) were also removed. The remaining sequences that
passed the quality trimming outlined above were mapped to the
human genome reference (NCBI build 37 v 1) downloaded from
NCBI using Bowtie with parameters (2v 3; at most 3 mismatches)
If one of the sequences from a paired end matched the human
genome, then both sequences were removed from the data-set.
The remaining reads were mapped against the human sequences
in the NCBI nr database using Basic Local Alignment Search Tool
(BLAST) in order to remove human sequences not present in the
NCBI human genome reference. For this additional check we
required at least 95% global identity (since BLAST is a local
alignment algorithm, our calculation also takes into account the
length of the unaligned segments flanking the ‘hit’ reported by
BLAST).
Comparative Assembly
We mapped and assembled the samples against reference
sequences for oral microbes extracted from the Human Oral
Microbiome Database (HOMD, http://www.homd.org) [64] as
follows:
1. We used MUMmer [65] (-maxmatch -l 20 -b) to map the
individual reads against the HOMD reference database.
2. Reads that mapped with higher than 80% global identity were
then assembled based on the mapped coordinates of the reads.
3. This process was repeated using a 90% similarity threshold, but
mapping the reads against the assemblies generated at step 2,
rather than against the HOMD database.
4. The resulting contigs were then combined with the results of a
de novo assembly of the data, as described in more detail
below.
All customized scripts used to run this analysis can be obtained
by request from the authors and will soon be released as part of an
open-source package for comparative assembly of metagenomic
data [Liu et al. in preparation].
De Novo Assembly Using SOAPdenovo
We used SOAPdenovo V. 1.04 [66] with parameters 2K2 3
and 2M 3, as previously used by the MetaHit project [52] to
assemble gut microbiome data.
Combining Comparative and de Novo Assembly Data
Contig sequences longer than 100 bp, which were generated by
our customized comparative assembly pipeline (workflow present-
ed above) and by SOAPdenovo, were combined and assembled
using MINIMUS [67] with the following parameters: (1) minimum
overlap length 40 bp, and (2) overlap error rate is 0.1.
Assembly and Gene Prediction of TM7 Genome
The reference genome of TM7a was downloaded from HOMD
(http://www.homd.org/). We pooled all available metagenomic
sequences together, and performed comparative assemblies against
the existing TM7a reference sequences as described above. The
resulting contigs were combined together with the de novo
assemblies of all metagenomic sequences using MINIMUS,
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was then further combined with the HOMD TM7a reference
genomic sequence. After assembly, scaffolds were created using
BAMBUS 2 using the available mate-pair information.
We used MetaGene [68] to predict genes (.=300 bp) in the
TM7 reference genome (NCBI accession NZ_ABBV00000000) as
well as in our combined assembly described above. We, then
mapped (using BLASTN) the predicted genes from our assembly
against the predicted genes from the TM7 reference genome. A
match was defined as E-value,=0.00001, % similarity .=90%,
and more than 50% of the query sequence is aligned. Genes found
in our assembly that did not match any gene in the reference strain
were considered novel and subjected to functional annotation
using COMBREX.
Estimation of SNP Rates and Genetic Diversity
After assembly, the shotgun reads were mapped back to the
contigs using Bowtie [69] allowing at most 3 mismatches. To
avoid sequencing and mapping errors we used a conservative
approach as suggested in [70]: we only retained SNPs occurring
in regions with a depth of coverage higher than 4, and with each
individual haplotype represented in at least two different reads.
The SNP rate was calculated using a 5 Kbp window and a
100 bp step size.
We adapted the approach used in [71,72] to infer the genetic
diversity h from metagenomic shotgun sequencing data using
composite likelihood estimators while accounting for a constant
sequencing error rate. First we classified the nucleotide positions of
the assembled contigs into k groups, where k is the maximum
depth of coverage of the contigs, and positions within the same
group have the same depth of coverage. The number of nucleotide
positions in each group is denoted by n1, n2,… ,nk. Considering
the large number of bacteria in the sampled community relative to
the number of reads sequenced, the probability that each read
derives from a different individual microorganism is close to one.
Thus, we have a population size equal to the depth of coverage at
every site in the assembled contigs [71]. Consequently, the
estimator can be obtained by calculating the expected number of
true SNPs and false SNPs due to sequencing errors [72]. Then for
a particular nucleotide group with the same depth d, assuming an
infinite sites model, the expected number of segregating sites is
hnd
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In our calculation, we assume a constant sequencing error rate
e=0.01. The h value is calculated using a 1 Kbp window moving
average (which is roughly the average gene size in bacteria) with
100 bp step size.
Regions of the genome that had a value of h more than 2
standard deviations higher than the average were flagged as
potential polymorphism hotspots (Table S3).
Clustering and Annotation of 16S rDNA Sequences
The entire set of trimmed 16S rDNA sequences were clustered
into Operational Taxonomic Units (OTUs) with the program
DNACLUST [73], using a 1% radius (2r 2). To obtain the
taxonomic identities, the OTU centers were aligned using BLAST
to the RDP database [74] augmented with oral clones from the
HOMD database [64], and were annotated using the lowest
common ancestor approach (similar to the approach in [75]). The
assignment process is conservative: (1) only sequence with at least
global 98% identity with the reference is classified; (2) if there are
more than one equally good best hits, then the sequence is
classified using the lowest common ancestor approach; (3)
otherwise it is classified as unknown. Finally, the taxonomic label
of the OTU center is transferred to the sequences from the same
OTU cluster. The resulting data was organized in a collection of
tables at different taxonomic levels containing each taxonomic
group as a row and each sample as a column. These tables formed
the substrate for the further statistical analyses.
Antibiotic Resistance Genes Annotation
Shotgun reads are annotated against the Antibiotic Resistance
Genes Database (ARDB) reference genes [76] using BLASTX
with the following thresholds: (1) at least 60 bp long high-scoring
segment pairs, and (2) 90% or 95% similarity cutoff at the amino
acid level.
Seed Functional Mapping
Sequences that were preprocessed for removal human contam-
ination were uploaded to the MG-RAST online webtool (version
2.0 [77] metagenomics.anl.gov/v2). Results were downloaded and
parsed into individual files, one per patient, using PERL. Only
annotations with a confidence of 1E-5 or lower were kept for
further processing resulting in 1,130,510 annotations (representing
75,742 distinct functional labels). In an attempt to correct for
under-counting of low-abundance sequences, we used the Laplace
correction and added one to all counts.
GSEA
To perform the gene set enrichment analysis (GSEA), we used
the gene set enrichment analysis (GSEA) tool version 2.07 [78],
downloaded from the Broad Institute website (www.broadinstitute.
org/gsea/index.jsp). GSEA was used to identify functional
categories that were enriched in disease or control patients.
Functional sub-classes from SEED (Version 12) [79] were used as
the gene sets (total of 669). We added two gene sets which were not
represented in SEED, ‘transposases’, and ‘transposon related’,
bringing the total to 671). These new gene sets were created by
Microbiome Deep Sequencing & Periodontal Disease
PLoS ONE | www.plosone.org 13 June 2012 | Volume 7 | Issue 6 | e37919searching for the title term (i.e. ‘transposases’, or ‘transposon
related’) in the functional descriptions of the full set of SEED
functional categories. We used the default parameter settings of
the GSEA software, with two exceptions. In our analysis, to rank
the functional classes, we used a ‘ratio of classes’ rather than the
‘signal to noise’ metric, and for the significance testing we
permuted the gene set instead of the phenotype. We selected and
reported all gene sets that had a p-value less than 0.005, and with a
false discovery rate q-value cut off of 0.01.
Calculating Tetramer Frequencies
K-mer frequencies, especially tetranucleotide frequencies in
prokaryotic genomes, have been shown to carry a phylogenetic
signal [80]. For each patient, we counted the occurrence of
each sequence motif of length 4 for all the pre-processed
sequence reads using a sliding window approach. The relative
frequency of each motif was calculated as the number of
occurrences of a specific motif (tetramer), divided by the total
number of motifs of length 4. The number of expected motifs of
length k based on the expectation from motifs of length k-1 was
estimated using a Markov chain [81]. For example, the
probability of observing a tetramer, such as ‘‘CTAG’’ is
estimated from the transition probability of observing a
‘‘CTA’’ motif adjacent to a ‘‘TAG’’ motif at ‘‘TA’’ dinucleo-
tides, or p(CTAG|CTA,TAG) = p(CTA) * p(TAG)/p(TA).
The observed motif frequencies were normalized by subtracting
the number of expected motifs from the number of observed
motifs, and dividing the result by the number of expected
motifs. Using these normalized values, we can visualize the
tetramer frequency counts directly and compare them across
samples. The tighter, linear grouping of the disease samples
suggests that the corresponding communities are composed of
organisms phylogenetically less diverse, compared to the larger,
more diverse cluster of healthy samples.
Taxonomic Diversity Analysis
Relative abundance estimates obtained from the 16S rDNA
sequencing data were used to compute the entropy (Shannon
diversity) for each of the 15 samples for which 16S rDNA data
were generated. Separate analyses were performed at the genus
and phylum levels, and the results were aggregated across clinical
status. The statistical significance of the observed differences was
estimated using a standard t-test.
Taxonomy Based PCA
The taxonomic composition of the samples was estimated
based on both 16S rDNA data (Methods above) and WGS data
using MetaPhyler [82]. Each sample was represented as a vector
of relative abundances of individual phyla, and the resulting
vectors were subjected to Principal Component Analysis using
the princomp function in R. Note that samples represented in
both the 16S rDNA and the WGS data are represented twice in
this analysis.
Enzyme Based PCA
After pre-processing, metagenomic sequences were annotated
with specific Kyoto Encyclopedia of Genes and Genomes
(KEGG) orthology (KO) codes using BLAST searches against
the KEGG sequence repository [83]. The KO numbers for
each protein were mapped to EC numbers, using a combination
of custom Perl scripts and a conversion table. The table was
generated from data available from the KEGG ftp server (ftp://
ftp.genome.jp/pub/kegg/). An E-value cut-off of 1E-05 was
applied to the resulting annotations to remove non-specific
BLAST hits. For each sample, we constructed a count matrix
containing the number of reads mapping to each enzyme. We
carried out a principal component analysis on this matrix, using
the ‘princomp’ function in Matlab implemented with the default
parameters. We then displayed the sample position on the first
and second principal components in Figure 3C to visualize each
sample’s relative distance.
Supporting Information
Figure S1 Histogram distribution of contig sizes. The
upper plot shows the distribution of contig size from TM7
reference genome, which is assembled from single-cell sequencing.
The lower plot shows the distribution of contig size from the
assembly that combines the contigs from TM7 reference genome
and metagenome. Contig sizes that are .=5000 bp are plotted as
5000 bp.
(TIF)
Table S1 Differential abundance of genera between
cases and controls. P-values were computed with Metastats
[30].
(PDF)
Table S2 Summary of microbial functions enriched in
diseased or control samples. CLINICAL – indicates whether
enrichment occurs in disease or control samples; METHOD –
method used to compute significance of enrichment; SIGNIFI-
CANCE – Method-specific assessment of the significance of
enrichment: for GSEA [87] we report both the p-value and the q-
value obtained by correcting for the False Discovery Rate (FDR);
for MetaPath [84] we report both the raw p-value for enrichment
(p-abund) and p-value corrected for the structure of the metabolic
network (p-struct).
(PDF)
Table S3 Genomic regions with nucleotide diversity h
values that are more than two standard deviations away
from the mean.
(PDF)
Table S4 COMBREX [55] functional annotations of new
genes predicted from TM7a metagenomic assembly.
(PDF)
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